Lucija Škara Abramović

Employment

• Croatian Institute of Public Health Molecular biologist
  2023 - Present
• School of Medicine, University of Zagreb
  2017 - 2022

Education

• National Centre for Public Health and Pharmacy HERA2 Metagenomics Workshop
  2025 - 2025
• European Centre for Disease Prevention and Control (ECDC) GenEpi-BioTrain Interdisciplinary genomic epidemiology and public health bioinformatics (Wave 6 - AMR)
  2025 - 2025
• European Centre for Disease Prevention and Control (ECDC) Genomic Epidemiology and Public Health Bioinformatics for Antimicrobial Resistance
  2025 - 2025
• European Centre for Disease Prevention and Control (ECDC) SQL for beginners 2025
  2025 - 2025
• HERA 2 HERA 2 WGS LONG-READ SEQUENCING WORKSHOP
  2025 - 2025
• European Centre for Disease Prevention and Control (ECDC) GenEpi-BioTrain Training in Genomic Epidemiology and Public Health Bioinformatics “Bridging the Gap” - Third edition (TB and AMR)
  2025 - 2025
• HERA 2 NGS Data Analysis WORKSHOP Introduction to command line-based bioinformatic tools
  2024 - 2024

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Enterovirus-D68—Neglected Pathogen in Acute Respiratory Infections: Insights from Croatia
  Pathogens 2026 DOI: 10.3390/pathogens15010048
  +Save
• A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma
  Cancer Cell International 2025 DOI: 10.1186/s12935-025-03887-8
  +Save
• Hedgehog signalling pathway inhibitors in the treatment of basal cell carcinoma: an updated review
  Journal of Drug Targeting 2025 DOI: 10.1080/1061186x.2025.2496470
  +Save
• Phenotypic and Whole-Genome Sequencing-Based Profiling of Antimicrobial Resistance and Virulence in Campylobacter spp. Isolated from Human Stool in a Croatian University Hospital
  Foodborne Pathogens and Disease 2025 DOI: 10.1089/fpd.2024.0173
  +Save
• LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA
  The Prostate 2024 DOI: 10.1002/pros.24749
  +Save
• Testicular Germ Cell Tumor Tissue Biomarker Analysis: A Comparison of Human Protein Atlas and Individual Testicular Germ Cell Tumor Component Immunohistochemistry
  Cells 2023 DOI: 10.3390/cells12141841
  +Save
• Methylation pattern of Caveolin-1 in prostate cancer as potential cfDNA biomarker
  Bosnian Journal of Basic Medical Sciences 2022 DOI: 10.17305/bjbms.2022.7497
  +Save
• Association of Vitamins D, B9 and B12 with Obesity-Related Diseases and Oral Microbiota Composition in Obese Women in Croatia
  Food Technology and Biotechnology 2022 DOI: 10.17113/ftb.60.02.22.7478
  +Save
• The utility of cfDNA in TGCT patient management: a systematic review
  Therapeutic Advances in Medical Oncology 2022 DOI: 10.1177/17588359221090365
  +Save
• Prostate Cancer—Focus on Cholesterol
  Cancers 2021 DOI: 10.3390/cancers13184696
  +Save